SWS Hemodialysis Care Co (688410) Fair Value & Analysis
Healthcare · CN · Market cap 4.6B CNY
Fair value as of: Jun 24, 2026
Analysis
SWS Hemodialysis Care Co (688410) currently trades at ¥14.19, while our model-based Fair Value estimate is ¥10.04 — implying the stock looks roughly 29.2% overvalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).
About the company
SWS Hemodialysis Care Co., Ltd. provides integrated blood purification solutions for renal failure and critically ill patients internationally. It offers blood purification consumables, chain hemodialysis center medical services, dialysis disposables, and a dialysis center intelligent management system, as well as operates chain dialysis centers. The company also offers blood purification equipment, which includes continuous blood purification equipment, hemodialysis machines, hemoperfusion machines and others. The company was founded in 2001 and is headquartered in Chongqing, China.
Open the full interactive analysis →
Similar stocks
Frequently asked questions
Is SWS Hemodialysis Care Co (688410) undervalued?
What is the fair value of 688410?
What is the quality score of 688410?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.